The simplified PE Severity Index (sPESI) is one of several validated prognostic tools for acute pulmonary embolism (PE). The European Society of Cardiology recommended the use of the sPESI to risk-stratify patients with acute PE into low risk (sPESI=0) and non-low risk (sPESI≥1) in order to guide treatment and disposition (Konstantinides 2014).
Read More
Tagged ‘Pulmonary’
Journal Review
Safety of PE Treatment with Rivaroxaban
Journal Review
Long-Term Outcomes in Submassive PE After Thrombolytics
There is scant evidence published on the long-term outcomes of systemic thrombolysis in acute submassive PE. Many advocate for the use of systemic thrombolysis to reduce morbidity (complications from chronic pulmonary hypertension) and mortality.
Read More
Journal Review
Age-Adjusted D-dimer (Using D-dimer Units)
Risk stratification tools like the Well’s and Geneva scores are useful for identifying patients in whom a venous thromboembolism (VTE) can be excluded with a negative D-dimer. This allows for decreased utilization of computed tomographic pulmonary angiography,
Read More
Journal Review
Normalization of Vital Signs Does Not Reduce the Probability of PE
In patients with symptoms of pulmonary embolism (PE), we often turn to vital signs, including heart rate, respiratory rate and pulse oximetry, as part of our initial impression of the patient.
Read More
